维普中文期刊产品整合服务
9篇 您的检索式:作者名="Deedigan"
    题名 作者 年代 出处 被引量
1Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-i- ndependent enhanced antitumor effects显示文摘Yu R Deedigan L Albarenque SM 2013Cell Death Dis2013,214,:1
2Targeting of XIAP combined with systemic mesenehymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells显示文摘Mohr A Albarenque S M Deedigan L 2010Stem Cells2010,28,11:1
3Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells显示文摘Mohr A Albarenque SM Deedigan L 2010Stem Cells2010,28,11:1
4Mesenchymal stem cells ex- pressing TRAIL lead to tumour growth inhibition in an experi- mental lung cancer model显示文摘Mohr A Lyons M Deedigan L 2008J Cell Mol Med2008,12,6:1
5Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells显示文摘Molr A Albarenque SM Deedigan L 0,,11:1
6IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancre- atic carcinoma cells显示文摘Baneker CK Yu R Deedigan L eta/ 2012Cancer Lett2012,316,2:1
7IFN-gamma combined with Targeting of XIAP leads to increased apoptosis - sensitization of TRAIL resistant Pancreatic carcinoma cells显示文摘Buneker CK Yu R Deedigan L 2012Cancer Lett2012,316,2:1
8Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model显示文摘Mohr A Lyons M Deedigan L 2008J Cell Mol Meal2008,12,6:1
9Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcino- ma cells显示文摘Mohr A Albarenque SM Deedigan L 2010Stem Cells2010,28,11:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费